Skip to main content
. 2018 Jan 3;9(9):8531–8541. doi: 10.18632/oncotarget.23989

Table 1. Mutations detected in candidate genes (BRAF, NRAS, and CDKN2A) among melanoma cell lines derived from primary and metastatic melanomas.

Cell line origin BRAF NRAS CDKN2A
Primary melanoma
GR-Mel
LCP-Mel V600R del ex 2
MNG-Mel
PNP-Mel V600E G101W
SBCL2 Q61L del ex 1, 2, 3
ST-Mel G466E
UACC 62 V600E
WM-115-4 V600D
Cutaneous melanoma metastasis
397-Mel del ex 2
LB-24-Mel
M14 V600E 455insCdel26 IVS1+2T>C
PR-Mel V600R
SN-Mel V600E
WM-266-4 V600D del ex 1
PE-MEL-41 V600E W110* A148T
PE-MEL-43 V600E W110* A148T
PE-MEL-47 V600E W110* A148T
Lymph node melanoma metastasis
13443-Mel
CN-Mel Q61R
CR-Mel Q61K del ex 2
GL-Mel del ex 2
LCM-Mel V600R del ex 1, 2
MAR-Mel
SK-Mel-28 V600E
COPA 159 V600E del ex 1,2,3
A375 V600E E61*; E69*
PNM-Mel V600E G101W
Mel 3.0 Q61L del ex 1, 2, 3
INT 9009 V600E del ex 1, 2, 3
MALME 37 V600E del ex 1, 2, 3
ME 33797 V600E
UACC 257 del ex 1, 2, 3

Abbreviations: del, deletion; ex, exon.